Trial Profile
A pilot study to examine the cure rates of oral miltefosine and sodium stibogluconate for treating Old World Cutaneous Leishmaniasis in Kandahar, Afghanistan
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 19 Dec 2018
Price :
$35
*
At a glance
- Drugs Miltefosine (Primary) ; Sodium stibogluconate; Sodium stibogluconate
- Indications Cutaneous leishmaniasis
- Focus Therapeutic Use
- Acronyms CLIK
- 14 Nov 2018 New trial record